B+
Bull case
20%
Probability
Target price
$32.98
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
ROIV
Roivant SciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Successful pivotal readouts or favorable regulatory outcomes derisk lead programs and trigger re-rating toward premium multiples and analyst highs.
Posture
Defensive
Lead driver
Value
What changed
7 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Equity dilution / financing risk
Momentum
63
Value
41
Sentiment
17
Setup hits (3d)
7 · Net Bullish
AI TargetsBase $25.37 · Bull $32.98 · Bear $20.30Analysis 2026-02-07; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-07 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $45.95
Why
Momentum63 · Δ7d +19.1
Value41 · Δ7d 0.0
Sentiment17 · Δ7d -11.9
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Confirming evidence
- • 7 setup hits (3d) with net bullish as of 2026-09-09.
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Equity dilution / financing risk
- • Negative pivotal/late-stage clinical readout
- • Failed or delayed readouts, weaker licensing outcomes, or financing pressure push valuation toward analyst lows and increase dilution risk.
Catalyst clock
2026-03-31
Analyst coverage refresh
Lead driver: Value · See fundamentals
Momentum
63
9% active weight
Current posture
7d trendImproving
Δ7d
+19.1
Δ21d
-14.7
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.1
Sentiment
17
62% active weight
Current posture
7d trendSoftening
Δ7d
-11.9
Δ21d
-6.5
Why this grade
Composite grade F. Momentum 62.8 / Value 41.2 / Sentiment 16.5
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-07. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$25.37
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$20.30
Analysis reference price unavailable
Analysis 2026-02-07 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$26.18B
Beta
1.23
Shares Out
722.32M
P/E (TTM) · Derived
-83.9
P/S (TTM)
728.71
P/FCF (TTM) · Derived
-31.84
Rev YoY
-33.5%
EPS YoY
-19.8%
Gross Margin
+43.4%
Op Margin
-18146.1%
Net Debt
-$4.19B
Current Ratio
16.72
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data